Top Industry Leaders in the Montelukast Intermediate Market
Latest Montelukast intermediates Companies Update
- Jan 2023:
The anti-allergy medication Fexofinadine Hydrochloride, which Morepen Laboratories Limited markets in India under the well-known brand Allegra, among other names, has acquired USFDA approval. This drug is the best-selling product of the French developer Sanofi Aventis. The most popular second-generation antihistamine medication for treating allergy and hay fever symptoms is fexofinadine. This approval of fexofenadine makes Morepen facilities in Baddi, in the Solan district of the State of Himachal Pradesh, the fifth to receive a USFDA product approval. One of the firm's major US clients, with which it has had enduring relationships for more than 20 years, has contracted with the company for regular deliveries of fexofinadine.List of Montelukast intermediates Key companies in the market
- VIVAN Life Sciences
- P.G. Shah & Co.
- Manus Aktteva Biopharma LLP
- Ortin Laboratories Limited.